Pages

Thursday 20 March 2014

The #NoMakeUpSelfie: why I'm on board

Is it a little narcissistic? Probably. Have I done one? Check it out below. To be honest, while there has been a lot of cynicism attached to the craze (of which I was a part of at first), if it's raising money for cancer research, who the hell cares?! At the time of writing this, over ONE MILLION POUNDS had been raised for Cancer Research UK! That's freaking unbelievable!!

And to all the men out there with their "Just a bunch of silly girls doing something silly" mantra, how is it any different to Movember?! Sit back down.



I heard a crazy fact the other day: out of your taxes, cancer research receives as much as the cost of a London pint (that's about £4.50 for those of you lucky enough not to know) each year. Now I work in cancer research, and I know that £4.50 doesn't go very bloody far. So as far as I'm concerned, the more money raised, the better. 

And as a side note, I don't think the craze of telling women they look beautiful without make up is a bad thing, is it? We get up, cover our faces in glorified paint and head out to work. While I'm aware I'm less likely to scare babies with my make up on, when you step back and look at what a large proportion of Western women do, it's a bit mad no?! 

Everyone's a winner: save money on beauty products, receive a compliment or two, and most importantly (obviously), raise money for cancer research. 

So text BEAT to 70099 to donate £3 to Cancer Research UK, and let's see if we can make it to two million. 

You can also text...

"CCUK21 £3" to 70070 to donate to Children with Cancer UK
"MOBILE" to 70550 to donate £5 to Macmillan Cancer Support

Or you can go to www.breakthrough.org.uk to donate to Breakthrough Breast Cancer

Wednesday 5 March 2014

Designer Drugs: Our Night At The Museum

On Wednesday, we ran a workshop at the London Science Museum, for the "Bio-revolution" Lates session. We wanted to introduce people to the ideas of investigating protein structure and using it to design drugs to treat cancer. 

As it's a Lates session, most people have got a beer or a glass of wine in hand, making for a very relaxed and entertaining evening! It was a fantastic chance to showcase our new 3D printed protein structures and drugs, and they went down a treat. It was such an invigorating experience; so many people asking questions and getting involved. It was also the most popular Lates session to date - nearly 7000 people showed up!! 

Although it was an incredible amount of fun, I was absolutely gutted that I didn't get the chance to go off and explore the rest of the museum myself. There was so much going on, and so many researchers there ready to get the public involved in their science. 

As for our session, it started with an animated video made by the very talented Jeroen Claus, explaining how some cancers develop and one of the ways in which researchers attempt to target it. You can watch the video here




After that, people got a chance to play with the 3D proteins themselves. We had big 3D printed HER2 proteins, with 3D printed flexible drugs that (may) fit into the ATP pocket (or binding site). We started by observing that while ATP fits, it falls out pretty easily when you tip the protein upside down. It was just a nice way of visualising the fact that ATP binds loosely, and a drug just needs to fit more tightly in order to compete with it. 

Enter our drugs (from the top of the fingers down to the palm): Staurosporine, ATP (for comparison), Lapatinib and Taxol.




Staurosporine fits really well - in fact, it fits too well. It fits so well that it likes to bind to loads of ATP pockets - not just the ones in HER2. The fact that it's so promiscuous means that a lot of messages that we need to be transmitted are blocked along with the HER2 ones, meaning that our cells die. So it's used in the lab, but is rubbish in the clinic. 

Taxol is massive. It's actually a natural molecule that was isolated from the Yew tree, and it took forever to recreate in the chemistry lab because of its unusual structure. That unusual bulky structure also makes it a poor fit for the ATP pocket. You can shove it in if you try (and believe me, some of our visitors definitely tried) but you get the idea that it wouldn't happen in the body naturally. Taxol is used to treat cancer though, as a chemotherapy agent. It targets the cytoskeleton (check out my last post for more info on that), stabilising the cell structure and preventing cell division. 

And finally, lapatinib: our winner. I think it looks like a longer ATP - and a lot of drugs that target these sorts of proteins are modelled on the structure of ATP, because we know that fits. It extends further into the back of the pocket, and will be interacting with the amino acids inside. Lapatinib is used as a secondary treatment for HER2-positive breast cancer in the US. 




This sort of personalised medicine isn't going to solve everything - drug resistance is still a big problem. But it does offer a more specific treatment with fewer side effects that chemotherapy. You can read more about targeted cancer therapies in far greater detail here

Overall, we had a lot of fun! 3D printed proteins were a great way to explain structure and drug development, and hopefully we'll get to use them a lot more in the future.